Efficacy and safety of solifenacin for overactive bladder: An updated systematic review and meta-analysis
Overactive bladder (OAB) is a chronic disease with the symptoms of urgency with or without incontinence. Solifenacin is an antimuscarinic drug that Excels in OAB treatment due to its specific bladder receptor targeting. While previous research had positive outcomes, reports of adverse events (AEs) h...
Saved in:
| Main Authors: | I Gede Yogi Prema Ananda, Radika Naufal Hadi Surya, Prima Ardiansah Surya, Alfin Putratama, Dimas Panca Andhika |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| Series: | Urology Annals |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/ua.ua_30_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of Combined Therapy With Silodosin and Solifenacin in Females With Overactive Bladder
by: Byeong Jo Jeon, et al.
Published: (2024-12-01) -
Efficacy and Tolerability of Solifenacin Fumarate with Overactive Bladder Patients: A Multicenter Observational Study
by: Jae Hun Shim, et al.
Published: (2021-04-01) -
Overactive Bladder: Where We Are and Where We Are Going
by: Charan S. Mohan, et al.
Published: (2021-09-01) -
Comparison Of Outcome And Side Effects Profile Of Treatment Of Overactive Bladder With Different Classes Of Drugs
by: Nazish Sarfraz, et al.
Published: (2023-12-01) -
Global insights into overactive bladder management: A survey of physician preferences and practices
by: Omer Anis, et al.
Published: (2025-09-01)